In contrast to paper solutions, electronic Clinical Outcome Assessment (eCOA) demonstrates strengths such as: Accuracy
Immunology Case Study
Immunology studies present specific challenges: their eCOA build can be complex, site staff must play a key role, and study duration can be very long whilst patients are in pain.
To overcome these challenges, Kayentis offers strong and global experience in immuno-inflammation trials, especially with:
- experienced teams and a powerful solution to face eCOA complexities,
- adapted options to support site staff,
- and additional features for the comfort of the patient
Therefore, Kayentis contributes to the success and quality of immunology clinical trials.
Learn more in the case study:
Early phase clinical research (phase 1 and 2a) focuses on characterizing the behavior of the
In a clinical trials environment that is moving increasingly towards digitalization and decentralization, it remains
In the ever-evolving landscape of biotechnology, groundbreaking advancements continue to shape the future of healthcare.
In this first episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Last update : 31 August 2022